Opinion
Video
Author(s):
The panel discusses data on the accuracy of MRI-targeted or fusion-based biopsy procedures compared with systemic biopsy or MRI alone.
FDA clears AI-powered application for measuring prostate volume
Dr. Murphy on increasing diversity in cancer clinical trials
AUA 2025: What to watch for in urologic oncology
Dr. Schwen on focal therapies for prostate cancer
Dose expansion begins in phase 1/2 trial of 67Cu-SAR-bisPSMA in mCRPC
Study underway to assess 3-fraction SBRT regimen in prostate cancer